<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is one of the most critical prognostic factors in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Although regional lymph nodes should be surgically resected and pathologically examined, techniques for the intraoperative diagnosis of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> remain to be well established </plain></SENT>
<SENT sid="2" pm="."><plain>Fluorescence diagnosis using <z:chebi fb="0" ids="17549">5-aminolevulinic acid</z:chebi> (5-ALA) is a promising technique for evaluating various <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>After exogenous administration of 5-ALA, <z:chebi fb="0" ids="15430">protoporphyrin</z:chebi> IX (PPIX) accumulates in malignant cells and can be detected as red fluorescence </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we investigated the usefulness of fluorescence diagnosis using 5-ALA for the detection of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in a mouse model of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>MATERIALS AND METHODS: An orthotopic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> model was prepared by inoculating the cecal wall of <z:mp ids='MP_0003815'>nude</z:mp> mice with HCA7, a human <z:mp ids='MP_0009314'>colon adenocarcinoma</z:mp> cell line </plain></SENT>
<SENT sid="6" pm="."><plain>After 3 wk, 40 mg/kg of 5-ALA was administered intraperitoneally (IP) or orally (PO) </plain></SENT>
<SENT sid="7" pm="."><plain>Fluorescence diagnosis with a D-Light System (Karl Storz) was then performed after 3 or 6 h </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: In the IP group, PPIX fluorescence was detected in metastatic lymph nodes as well as in other malignant lesions, including <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> and abdominal implantations, while non-metastatic nodes were fluorescence-negative </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast, no obvious fluorescence was detected in cancerous tissues in the PO group </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: PPIX fluorescence induced by intraperitoneal injection of 5-ALA allows metastatic lymph nodes to be accurately diagnosed in this mouse model </plain></SENT>
<SENT sid="11" pm="."><plain>This technique may facilitate the intraoperative diagnosis of <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> from <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in a clinical setting </plain></SENT>
</text></document>